FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a composition containing an effective amount of exenatide, a protease inhibitor, ethylene diamine tetraacetic acid, omega-3 fatty acid and a coating, which inhibits exenatide splitting in an individual's stomach; the above composition represents a pharmaceutical composition for oral application for treating the diseases, wherein agonist action on glucan-like peptide (GLP-1) is favourable.
EFFECT: invention provides the blood sugar control following the glucose administration.
19 cl, 4 dwg, 2 tbl, 8 ex
